Business Wire

Rapyd’s 2026 State of Stablecoins: Businesses Move En Masse as Stablecoins Go Mainstream

14.1.2026 14:00:00 CET | Business Wire | Press Release

Share

Rapyd, a leading global fintech company, released its 2026 State of Stablecoins Report, revealing that stablecoins have reached a tipping point and are becoming a foundational component of global commerce rather than a niche digital asset.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114427729/en/

Rapyd research shows 64% of businesses already use stablecoins or plan to within three years, as speed, cross-border efficiency, and cost savings drive mainstream adoption.

The report shows the market has moved decisively into active, real-world use. Today, nearly one in five businesses already consider stablecoins a mainstream financial tool. Looking ahead, a much larger majority (76%) believe stablecoins are either already mainstream or will become mainstream within the next five years.

This shift in perception is translating into action: 64% of businesses surveyed either use stablecoins today or plan to adopt them within the next three years, signaling a move from crypto curiosity to institutional-grade execution.

The findings, drawing on a global survey of business decision-makers across multiple industries in APAC, the Americas, and EMEA, highlight how stablecoins are increasingly used to improve operational speed, reduce costs, and simplify cross-border payments and treasury operations.

Key findings from the State of Stablecoins Report include:

  • Mainstream momentum is accelerating: Stablecoin utilization among businesses has reached 34%, with a strong adoption pipeline with 48% of organizations planning to adopt stablecoins within the next 12 months.
  • Cross-border commerce is the primary use case: 72% of businesses rank faster payments and settlements as a key benefit, while 62% cite easier cross-border transactions.
  • Stablecoins are delivering measurable financial impact: 60% of organizations report cost savings as a primary benefit, demonstrating that stablecoins are now a profitability driver rather than a technology experiment.
  • Trust is high, but regulation remains the main concern: Over 83% of businesses rate their trust in stablecoins as moderate to high, while regulatory uncertainty remains the top barrier to adoption.
  • Smaller businesses are leading the way: Companies with 51–100 employees show the highest current usage at 50%, while larger enterprises remain more cautious.

Treasury moves to the center of stablecoin adoption

The report points to a shift in how businesses approach treasury operations. Based on Rapyd’s research findings, faster settlements and cross-border payments consistently emerge as the primary drivers of stablecoin adoption, underscoring the importance of speed and efficiency in global money movement. From Rapyd’s perspective, stablecoins play a growing role in enabling funds to move more quickly across entities and geographies, helping businesses operate with greater flexibility and less friction.

Taken together, these findings highlight a broader move from experimentation toward execution in how businesses approach global payments and treasury infrastructure.

“Stablecoins have crossed a threshold where the conversation is no longer about potential, but about execution,” said Arik Shtilman, CEO and Co-Founder of Rapyd. “Our research shows businesses are using stablecoins to move money faster, lower costs, and operate more efficiently internationally. This is not about speculation. It is about building modern financial infrastructure that works at global scale.”

For CFOs and corporate treasuries, the report underscores a clear shift in perception. Stablecoins are no longer viewed as alternative assets, but as liquidity tools. Businesses are using stablecoins to accelerate payments, reduce FX and banking fees, and enable just-in-time funding across regions to free up capital.

“Treasury teams are under increasing pressure to manage liquidity in real time across multiple markets,” said Kristin Reischel, Senior Director of Solutions and Partner Marketing at Rapyd. “What we are seeing in this research is a practical shift. Stablecoins allow businesses to deploy capital globally without the friction of traditional banking structures. That flexibility is becoming essential for companies operating across borders.”

While regulatory uncertainty remains the leading concern for businesses exploring stablecoins, the report finds that trust in the technology itself is already well established. This gap between confidence and adoption highlights the importance of compliant infrastructure and operational expertise to support enterprise use at scale.

Rapyd’s 2026 State of Stablecoins Report is available now and provides a detailed analysis of adoption trends, use cases, and implications for global payments and treasury operations.

Download the full report here.

About Rapyd

Rapyd lets you build bold. Liberate global commerce with all the tools your business needs to create payment, payout and fintech experiences everywhere. From Fortune 500s to ambitious business and technology upstarts, our payments network and powerful fintech platform make it easy to pay suppliers and get paid by customers—locally or internationally.

With offices worldwide, including London, Tel Aviv, Dubai, Iceland, Amsterdam, Miami, Hong Kong and Singapore, we know what it takes to make cross-border commerce as easy as being next door. Rapyd simplifies payments so you can focus on building your business.

Get the tools to grow globally and learn about our products, solutions and partner programmes at www.rapyd.net. Follow: Blog, Insta, LinkedIn, Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114427729/en/

Contacts

Media Contact: press@rapyd.net

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye